John Cush, MD
Enriched profileExecutive Editor, RheumNow.com; Professor of Internal Medicine, TCU Burnett School of Medicine · TCU Burnett School of Medicine
John Cush is Executive Editor, RheumNow.com; Professor of Internal Medicine, TCU Burnett School of Medicine at TCU Burnett School of Medicine. ClinicalTrials.gov lists 1 registered study with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
John Cush, MD, is Executive Editor, RheumNow.com at TCU Burnett School of Medicine (Fort Worth, TX) / RheumNow.com. The public record shows 98 publications with 10,888 citations (h-index 41), centered on Rheumatoid Arthritis. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 18 companies, 1 NIH-funded awards (1995–1999).
- Top research focus: Rheumatoid Arthritis
- 1 registered trials on ClinicalTrials.gov
- Open Payments reporting from 18 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →tregmd.com ↗
- Member
Arthritis Advisory Committee, U.S. Food & Drug Administration
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ccrheumatology.com ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
- The Controlled Trial of Apremilast for Rheumatoid Arthritis Treatment (CARAT)
Sponsor: Baylor Research Institute
Industry payments
Updated 27 Aug 2026
18 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20259 payments$340,500openpaymentsdata.cms.gov ↗
- Novartis Pharmaceuticals CorporationProgram year202544 payments$229,641openpaymentsdata.cms.gov ↗
- Genentech USA, Inc.Program year20251 payment$28,000openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
40.6%Opioid Agonist14.7%Tramadol Hcl100%Part D≥45 patientsGabapentinoids7.4%Gabapentin89%Pregabalin11%Part D<11 patientsCancer & immunology
21.7%Folate Analog Metabolic Inhibitor7.6%Methotrexate100%Part D≥36 patientsTNF inhibitor5.7%Humira(Cf)36%Enbrel25%Humira(Cf) Pen21%Enbrel Sureclick17%Part D<11 patientsMusculoskeletal
18.5%Xanthine oxidase inhibitor5.7%Allopurinol100%Part D≥20 patientsCentral alpha-2 Adrenergic Agonist5.2%Tizanidine Hcl100%Part D≥32 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
1 NIH research award on record, funded 1995–1999 per NIH RePORTER. The latest:
- METHOTREXATE FOR TREATMENT OF OSTEOARTHRITIS OF THE KNEE
University of Texas Sw Med Ctr/dallas
FY1999M01RR000633 - METHOTREXATE FOR TREATMENT OF OSTEOARTHRITIS OF THE KNEE
University of Texas Sw Med Ctr/dallas
FY1998M01RR000633 - METHOTREXATE FOR TREATMENT OF OSTEOARTHRITIS OF THE KNEE
University of Texas Sw Med Ctr/dallas
FY1997M01RR000633
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/cv/john-cush-md-1
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
rheumnow.com/team
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →rheumnow.com ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- Rheumatology fellowship
University of Texas Southwestern Medical Center / Parkland Memorial Hospital, Dallas
1987provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
- Internal Medicine residency
Coney Island Hospital, NYC
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Editorial & leadership roles
journal and society appointments- Executive Editor
RheumNow.com
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rheumnow.live ↗ - Professor of Internal Medicine
TCU Burnett School of Medicine, Fort Worth, TX
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →tregmd.com ↗ - Director of Clinical Rheumatology
Baylor Research Institute
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →tregmd.com ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →the-rheumatologist.org ↗
- Teacher of the Year
Internal Medicine Residency Program, Presbyterian Hospital of Dallas, 1998-99
1998provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Secondary affiliations
appointments beyond the home institution- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ccrheumatology.com ↗
- Baylor University Medical Center
professor of medicine and rheumatology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →tregmd.com ↗ - St. George's University School of Medicine
Chair of Academic Board of Trustees
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ccrheumatology.com ↗
Media & interviews
press, podcasts and appearances- Executive Editor / Founder of RheumNow.com
weekly RheumNow Podcast reviewing rheumatology news, journal reports, and regulatory decisions
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rheumnow.podbean.com ↗ - EMJ Podcast Interview with Dr. Jack Cush
discussed novel treatment avenues for rheumatic diseases, AI and telemedicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rheumnow.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →vumedi.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
David J. Hunter
The University of Sydney
Aziz Sheikh
Universiti Malaysia Terengganu
Nima Hafezi‐Nejad
The University of Sydney
Gelin Xu
Second Affiliated Hospital of Nanjing Medical University